Daily Management Review

Foreign Drug Makers Present Lowest Price Global To Enter Chinese Reimbursement Scheme


In China, drug makers slash price and hope to recover the same in volume while some warn against commotion for the same in other drug markets.

Various drug manufacturers, like Roche and Novartis’, are going to cut down prices in China by “an average of 61%” for their “newest drugs”. This step comes as an attempt to fall in the category of “a national reimbursement scheme”.  
Being part of the said list will increase sales as it will allow the companies to reach out to “smaller and less-affluent Chinese cities”. However, some people from the industry are of the opinion that slashing prices steeply only in China could draw flacks and criticism from other drug markets and manufacturers alike.
The Chinese reimbursement scheme list will include seventy new drugs which will include Pertuzumab, treatment for breast cancer from Roche under the trade name “Perjeta”, Omalizumab, for dermatitis from Novatis’ under Xolair brand, Adalimumab, by AbbVie for arthritis, among others, according to the website of “National Healthcare Security Administration”.
As per Reuters:
“Also included was cancer treatment Tyvyt, or Sintilimab, co-developed by Chinese drugmaker Innovent Biologics (1801.HK) and Eli Lilly (LLY.N). It is considered to be a PD-1/PD-L1 treatment, a category of novel drugs that work on the immune system to fight cancer cells”.
However analysts think that including Tyvyt in the list would give it an advantageous edge over the foreign drugs.
People of China get to use “state medical insurance” to pay a large portion of the drug costs is they are named in the above mentioned NHSA list. Furthermore, a statement from the same organisation also informed that the new addition of imported medicine to the list came in their “lowest prices globally”.
In the words of Loncar Investments’s C.E.O, Brad Loncar:
“China is and will be the ultimate high-volume, low-price market, and so international companies feel that they’ll have to take a big pay cut but make up for the volume”.
Likewise, medicines for diabetes and tumor saw price reduction of sixty five percent, as per the NHSA.

Science & Technology

Financial giants and US government turn to quantum computers

Long Way To Go For Coronavirus Vaccine, Say Drgumakers

Google's subsidiary launches recognition service for photoshopped images

Unapproved Drug For Coronavirus Treatment And Testing Given By Gilead Sciences

Live Facial Recognition Cameras Will Be Used By London Police

Driverless Vehicle For Its Ride-Sharing Service Unveiled By GM’s Cruise

Amazon will allow customers to pay with palms instead of cards

Complete Computer System For Self Driving Cars Launched By Qualcomm

In A Lifetime We Could Accumulate 20Kg Micro-Plastic In Our Body

Creator Of The First 'Gene-Edited' Babies Of The World Gets 3 Year Jail Term In China

World Politics

World & Politics

Ex-head of Mexican Pemex will be transferred to Madrid prison

China Releases First Detailed Study Of Coronaviurs Attack, Finds Elderly At Most Risk

EBA Finds Alarming Compliance Results For Gender Diversity Among Banks

Record high temperature observed in Antarctica

Venezuela to initiate international litigation against USA because of sanctions

Coronavirus Death Toll 204 In China, US Asks Americans Not To Go China

Hong Kong protesters block railway to mainland

Heavy rain kills 47 people in southeast Brazil